The Minister of Health, Dr. Sabin Nsanzimana, has cautioned that despite progress made in combating HIV/AIDS, the virus remains a serious threat and is increasingly re-emerging among young people. The ...

The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) has announced that it has signed an access agreement with Pharmaceutical Company Gilead Sciences to procure lenacapavir, a ...

Severe cuts to international aid are disrupting lifesaving HIV services in vulnerable countries, with UNAIDS warning of millions of preventable infections and deaths if support isn’t restored.

As global funding for HIV continues to face significant setbacks due to reduced international aids from donor countries, ...

Strategies that address population-specific concerns about medical mistrust and employ operational tactics, including staff ...

The Minister’s address was particularly notable for the announcement of a planned rollout of lenacapavir, a biannual ...

Gilead has partnered with Global Fund to supply lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP).

As global funding for HIV continues to decline due to reduced international aid from donor countries, the 7th National ...

Through a strategic, non-profit agreement, Gilead will supply up to two million doses of the long-acting HIV prevention drug ...

Gilead Sciences, Inc. (GILD) on Wednesday announced a strategic partnership agreement with the Global Fund to combat AIDS, ...